共 50 条
- [8] Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis Journal of Neurology, 2016, 263 : 327 - 333
- [10] Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis NEUROLOGIA, 2014, 29 (04): : 210 - 217